Stock listing

Xetra:NVV1 Novavax, Inc. Aktie

German listing (Xetra) of Novavax, Inc. · home listing NASDAQ:NVAX

Follow Novavax, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:NVAX

$10.82 USD -0.44 (-3.9%)

Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:NVAX

Since Jul 6, 2026 +15.7% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits
Day range
$10.76 – $11.97 USDOct 19, 2026
Volume
6.17M sharesOct 19, 2026
Market value
$1.78B USDAt the close on Oct 19, 2026 · price × 164.9M shares outstanding
Novavax, Inc. logo
Ticker
Xetra:NVV1
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Xetra
Currency
EUR

What changed lately

Calls

Replays

  • Novavax (NASDAQ:NVAX) Q2 2026 Earnings Call

    Thu, Aug 06, 2026 · 8:30 AM ET

    Watch Transcript

  • Novavax (NASDAQ:NVAX) Q1 2026 Earnings Call

    Wed, May 06, 2026 · 8:30 AM ET

    Watch Transcript

  • Novavax (NASDAQ:NVAX) Q4 2025 Earnings Call

    Thu, Feb 26, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

Novavax to Participate in September Investor Conferences

Sep 2, 2026

Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season

Aug 28, 2026

Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights

Aug 6, 2026

Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026

Jul 30, 2026

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

Jun 1, 2026

Novavax to Participate in BofA Securities 2026 Health Care Conference

May 7, 2026

Novavax Reports First Quarter 2026 Financial Results and Operational Highlights

May 6, 2026

Novavax to Report First Quarter 2026 Financial Results on May 6, 2026

Apr 29, 2026

Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

Mar 30, 2026

Nuvaxovid (Novavax) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Mar 13, 2026

All Novavax, Inc. news

Decks

Novavax, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
19 in the last 12 months · 274 in all · newest Sep 2, 2026 · oldest 2019
Calls
22 calls with a replay · 22 with a transcript · latest Aug 6, 2026
Decks
38 decks · latest Aug 6, 2026

Where Novavax, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:NVAX · Home listingNASDAQUnited StatesUSD
gettex:NVV1gettexGermanyEUR
Tradegate:NVV1TradegateGermanyEUR
BOATS:NVAXBOATSUnited StatesUSD
LS Exchange:A2PKMZLS ExchangeGermanyEUR
BMV:NVAXBMVMexicoMXN
Lang & Schwarz:A2PKMZLang & SchwarzGermanyEUR
Frankfurt:NVV1FrankfurtGermanyEUR
LSIN:0A3SLSINUnited KingdomUSD
VIE:NVAXViennaAustriaEUR
Dusseldorf:NVV1DusseldorfGermanyEUR
Stuttgart:NVV1StuttgartGermanyEUR
SIX Swiss:NVAXSIX SwissSwitzerlandCHF
BIVA:NVAXBIVAMexicoMXN
BSESOF:NVV1BSESOFBulgariaEUR
SIX Swiss:NVAX.USDSIX SwissSwitzerlandUSD
BX Swiss:NVV1BX SwissSwitzerlandCHF
Munich:NVV1MunichGermanyEUR
Hamburg:NVV1HamburgGermanyEUR
Hanover:NVV1HanoverGermanyEUR
Xetra:NVV1 · This pageXetraGermanyEUR

Log in to ask 6ix AI your own questions about Novavax, Inc.